Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

NCT00539773 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Transitional Carcinoma of Urinary Bladder

Interventions

DRUG: BCG, Interferon

Sponsor

King Faisal Specialist Hospital & Research Center